Medtronic receives FDA approval for Intellis chronic pain management platform: 5 key points

Spinal Tech

The FDA approved Medtronic's Intellis platform.

Here are five key points:


1. The Intellis platform is designed for chronic intractable pain management.


2. Medtronic designed the platform to enhance existing spinal cord stimulation systems, by improving elements such as battery power.


3. The platform is able to power the Evolve workflow, which is intended to standardize guidance as well as balance dose therapy settings.


4. Managed on the Samsung Galaxy Tab S2 tablet, the Intellis platform records and tracks patient activity at all times.


5. Durham, N.C.-based Duke University Medical Center surgeons were among the first to implant a U.S. patient with the Intellis device.



Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.


Featured Webinars

Featured Whitepapers